» Articles » PMID: 37540596

Topography of Mutational Signatures in Human Cancer

Overview
Journal Cell Rep
Publisher Cell Press
Date 2023 Aug 4
PMID 37540596
Authors
Affiliations
Soon will be listed here.
Abstract

The somatic mutations found in a cancer genome are imprinted by different mutational processes. Each process exhibits a characteristic mutational signature, which can be affected by the genome architecture. However, the interplay between mutational signatures and topographical genomic features has not been extensively explored. Here, we integrate mutations from 5,120 whole-genome-sequenced tumors from 40 cancer types with 516 topographical features from ENCODE to evaluate the effect of nucleosome occupancy, histone modifications, CTCF binding, replication timing, and transcription/replication strand asymmetries on the cancer-specific accumulation of mutations from distinct mutagenic processes. Most mutational signatures are affected by topographical features, with signatures of related etiologies being similarly affected. Certain signatures exhibit periodic behaviors or cancer-type-specific enrichments/depletions near topographical features, revealing further information about the processes that imprinted them. Our findings, disseminated via the COSMIC (Catalog of Somatic Mutations in Cancer) signatures database, provide a comprehensive online resource for exploring the interactions between mutational signatures and topographical features across human cancer.

Citing Articles

Polyguanine microsatellites are robust replication clocks in cancer.

Gejman R, Izar B Nat Genet. 2025; 57(3):489-491.

PMID: 39962239 DOI: 10.1038/s41588-025-02098-1.


Deaminase-Driven Reverse Transcription Mutagenesis in Oncogenesis: Critical Analysis of Transcriptional Strand Asymmetries of Single Base Substitution Signatures.

Steele E, Lindley R Int J Mol Sci. 2025; 26(3).

PMID: 39940758 PMC: 11817618. DOI: 10.3390/ijms26030989.


Contributing factors to the oxidation-induced mutational landscape in human cells.

Cordero C, Mehta K, Weaver T, Ling J, Freudenthal B, Cortez D Nat Commun. 2024; 15(1):10722.

PMID: 39715760 PMC: 11666792. DOI: 10.1038/s41467-024-55497-z.


Computational investigation of missense somatic mutations in cancer and potential links to pH-dependence and proteostasis.

Sallah S, Warwicker J PLoS One. 2024; 19(11):e0314022.

PMID: 39561123 PMC: 11575792. DOI: 10.1371/journal.pone.0314022.


Widespread mutagenesis and chromosomal instability shape somatic genomes in systemic sclerosis.

Vijayraghavan S, Blouin T, McCollum J, Porcher L, Virard F, Zavadil J Nat Commun. 2024; 15(1):8889.

PMID: 39406724 PMC: 11480385. DOI: 10.1038/s41467-024-53332-z.


References
1.
Ong C, Corces V . CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet. 2014; 15(4):234-46. PMC: 4610363. DOI: 10.1038/nrg3663. View

2.
Gates L, Shi J, Rohira A, Feng Q, Zhu B, Bedford M . Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation. J Biol Chem. 2017; 292(35):14456-14472. PMC: 5582839. DOI: 10.1074/jbc.M117.802074. View

3.
Jakobsdottir G, Brewer D, Cooper C, Green C, Wedge D . APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types. BMC Biol. 2022; 20(1):117. PMC: 9124393. DOI: 10.1186/s12915-022-01316-0. View

4.
Petljak M, Alexandrov L, Brammeld J, Price S, Wedge D, Grossmann S . Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis. Cell. 2019; 176(6):1282-1294.e20. PMC: 6424819. DOI: 10.1016/j.cell.2019.02.012. View

5.
Kent W, Sugnet C, Furey T, Roskin K, Pringle T, Zahler A . The human genome browser at UCSC. Genome Res. 2002; 12(6):996-1006. PMC: 186604. DOI: 10.1101/gr.229102. View